First Page | Document Content | |
---|---|---|
![]() Date: 2012-04-11 15:23:45Medicine Gadopentetic acid Gadolinium Nephrogenic systemic fibrosis Magnetic resonance imaging Pentetic acid Renal failure Lorazepam MRI contrast agent Chemistry Matter Nephrology | Add to Reading List |
![]() | Contrast enhancement in MR imaging: New options, new techniques, new opportunities Nephrogenic systemic fibrosis update 2014: Fact versus theory Emanuel Kanal, MD, FACR, FISMRMDocID: 1g70b - View Document |
![]() | [removed] ® HIGHLIGHTS OF PRESCRIBING INFORMATIONDocID: Wwpb - View Document |
![]() | HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use OMNISCAN safely and effectively. See full prescribing information for OMNISCAN. OMNISCANTM (gadodiamide) Injection fDocID: LwKY - View Document |
![]() | OPTIMARK (gadoversetamide) injection LabelDocID: KSKv - View Document |
![]() | FDA Patient Safety News: Show #54, August 2006DocID: HDJ2 - View Document |